Skip to main content
Full Schedule
Browse Schedule
Podium and Symposium Sessions
Browse by Date
Saturday, February 15, 2020
Sunday, February 16, 2020
Monday, February 17, 2020
Browse by Track
Browse by Title
Browse by Presenter
Posters
Browse By Title
Browse by Presenter
Browse by Time
Browse by Monitor
Faculty
Exhibitors
Sponsors
Conference App
Registration
Housing
CME Information
CME Evaluation
Login required
Login
Toggle navigation
Home
Full Schedule
Browse Schedule
Podium and Symposium Sessions
Browse by Date
Saturday, February 15, 2020
Sunday, February 16, 2020
Monday, February 17, 2020
Browse by Track
Browse by Title
Browse by Presenter
Posters
Browse By Title
Browse by Presenter
Browse by Time
Browse by Monitor
Faculty
Exhibitors
Sponsors
Conference App
Registration
Housing
CME Information
CME Evaluation
Login required
Tweets by SSO 2020 Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Title
Browse by Poster Title
Browse by Poster Title
0
results found.
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
4
LSM P2
40 Minutes is Enough: Lymphoscintigraphy with Novel Agent Reduces Time Needed for Mapping
Favorite
5
PM P1
5-hydroxymethylation Signatures in Plasma Circulating Cell-Free DNA as Markers for Appendiceal and Colorectal Peritoneal Metastasis
Favorite
a
PM P32
A Conservative Approach To Enteral Feeding After Cytoreductive Surgery and HIPEC Leads To Improved Outcomes
Favorite
PM P17
A Multi-institutional Analysis of Major Organ Resection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Favorite
LSM P3
Active Surveillance of Melanoma Patients with Sentinel Node Metastasis: An International Multi-Institution Evaluation of post-MSLT-2 Adoption and Early Outcomes
Favorite
LSM P4
Adjuvant Therapy Failure Patterns in the Post-MSLT-2 era
Favorite
HPB P3
Analysis of Cholyglycine Acid as a Biomarker for the Early Diagnosis of Liver Disease
Favorite
O P1
Analysis of ERAS Protocol in Patients Undergoing Pancreaticoduodenectomy
Favorite
PM P27
Anesthesia and Pain Management of Pediatric Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors Utilizing a Tunneled Thoracic Epidural; Initiation of a New Pediatric HIPEC Program
Favorite
PM P2
Association of Muscle Quantity and Frailty on Short-term Outcomes of CRS/HIPEC in Patients with Appendiceal Cancer
Favorite
c
PM P11
Carboplatin Hyperthermic Intraperitoneal Chemotherapy is Safe and Efficacious in Recurrent and Advanced Ovarian Cancer
Favorite
AR P2
Cellular Immunoprofile of Peritoneal Environment during HIPEC Procedure
Favorite
HPB P4
Clinical Significance of SMAD4 Mutation Status in Patients with Resected Colorectal Liver Metastases
Favorite
PM P28
Completeness of Cytoreduction, Regardless of Tumor Burden, is Associated with Improved Survival after CRS/HIPEC for LAMN
Favorite
PM P33
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin in Pediatric Patients with Peritoneal Mesothelioma: A Single Institution Experience and Long Term Follow Up
Favorite
O P2
Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemotherapy and Subsequent Fertility: Should We Be Doing More?
Favorite
d
PM P29
Development of a Novel Enhanced Recovery After Surgery Protocol (ERAS) For Cytoreductive Surgery & HIPEC
Favorite
e
LSM P5
Exploring Head and Neck Melanoma Sentinel Lymph Node Outcome Compliance with Multicenter Selective Lymphadenectomy Trials Predicted Outcome
Favorite
f
LSM P1
Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-center Analysis
Favorite
O P6
Focused Ultrasound and Concurrent Chemotherapy for Locally Advanced Pancreatic Cancer: A Systematic Review
Favorite
g
PM P3
Gold Nanorod-Mediated Hyperthermia Can Improve Chemotherapeutic Efficacy in HIPEC
Favorite
h
O P3
Hospital Variation in Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement
Favorite
i
PM P4
Impact of Cellularity in Peritoneal Metastases on Survival in Patients with Low-Grade Appendiceal Mucinous Neoplasm (LAMN)
Favorite
PM P12
Impact of Histology on Survival in Colon Cancer with Peritoneal Carcinomatosis: Does it really matter?
Favorite
PM P5
Implications of Postoperative Complications on Survival after CRS/HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
Favorite
PM P6
Incomplete Cytoreductive Surgery for Appendiceal and Colorectal Peritoneal Carcinomatosis: Characteristics and Outcomes of an Overlooked Group
Favorite
PM P34
Influence of Older Age on the Prognosis after CRS+HIPEC for Peritoneal Carcinomatosis of Appendiceal Origin
Favorite
LSM P6
Institutional Percutaneous Hepatic Perfusion (PHP) for Unresectable Liver Metastases
Favorite
PM P18
Interim Results of Phase II Trial for Novel Magnetic Resonance Imaging of Peritoneal Mesothelioma
Favorite
PM P35
Is Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Safe in Septuagenarians?
Favorite
l
PM P13
Laparoscopic HIPEC for Low-volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma
Favorite
PM P14
Lymph Node Metastasis in Mucinous Appendiceal Adenocarcinoma
Favorite
m
PM P19
Mitomycin C versus Oxaliplatin During Cytoreductive Surgery and HIPEC for Peritoneal Metastases Secondary to Colorectal Carcinoma: A Retrospective Analysis
Favorite
n
PM P20
National Trends In Cytoreductive Surgery with Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin: An Analysis of the National Cancer Database
Favorite
o
PM P21
Outcomes in Elderly Ovarian Cancer Patients Treated with CytoreductiveSurgery plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
Favorite
PM P30
Outcomes of CS-HIPEC Among Patients with Colorectal and Appendiceal Adenocarcinoma Versus Signet-ring Cell Carcinoma
Favorite
PM P7
Outcomes of Palliative CRS/HIPEC for Patients with Advanced Peritoneal Carcinomatosis from Appendiceal Cancer
Favorite
p
PM P22
Pelvic Anastomosis without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Favorite
O P5
Percutaneous Cryoablation: A Novel First-Line Therapy for Extra-Abdominal Desmoid Tumors
Favorite
PM P8
Preoperative Lymphocyte-to-Monocyte Ratio Predicts Survival in HIPEC/ CRS for Colorectal and Appendiceal Adenocarcinoma
Favorite
PM P15
Prognostic Factors And Outcomes Of Non-Invasive Mucinous Appendiceal Neoplasms With And Without Peritoneal Spread
Favorite
r
PM P23
Rate of Peritoneal Carcinomatosis in Surgically-Resected Stage II and III Colon Cancer
Favorite
HPB P1
Risk of Performing Concurrent Procedures with Hepatic Artery Infusion
Favorite
HPB P2
Robotic Major Hepatectomy: An Institutional Eexperience and Clinical Outcomes
Favorite
s
PM P36
Should Ascites be a Contraindication to Laparoscopic HIPEC in Gastric Cancer?
Favorite
PM P9
Site-specific Molecular Comparison Between Primary Gastric (GC) and Gastroesophageal Junction (GEJ) Cancer Emphasizing Peritoneal Metastases (PM)
Favorite
PM P24
Survival Benefits of Redo Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Recurrent Peritoneal Carcinomatosis
Favorite
PM P26
Symptomatic Presentation Harbors Worse Prognosis With Low Grade Appendiceal Mucinous Neoplasm
Favorite
t
PM P37
The Impact of Postoperative Peritoneal Carcinomatosis Index on Survival of Patients with Peritoneal Surface Malignancy from Appendiceal Origin after CRS/HIPEC
Favorite
PM P10
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC
Favorite
LSM P7
The Physician Assistant's Role in Administering T-VEC for Advanced Melanoma: a Single Institution Experience
Favorite
PM P16
The Use of Predictive Modeling for Prolonged Hospital Length of Stay in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Favorite
u
O P7
Upper Abdominal Stopflow Perfusion - The Surgical Technique Behind Locally High Drug Concentrations
Favorite
v
PM P31
Volume of Intraoperative Crystalloid Administration is Associated with Postoperative Respiratory Failure following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
Favorite
y
AR P3
Y-90 PET Dose verification for Liver Cancer Y-90 Radioembolization Personalized Dosimetry
Favorite
Back to Top
